Skip to content

Epidural spinal nerve anterior root stimulation technique for the treatment of lower limb motor dysfunction after chronic spinal cord injury

Epidural spinal nerve anterior root stimulation technique for the treatment of lower limb motor dysfunction after chronic spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126461
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb motor dysfunction after paraplegia

Interventions

Experimental group:Precise Placement of Epidural Stimulator in the Spinal Canal

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Paralysis following central nervous system injury (ASIA A, B, C), especially spinal cord injury above the T10 level; 3. Patients with injury duration of more than 9 months but within 5 years; 4. Mainly presenting with motor and sensory dysfunction in both lower limbs and having failed prior stepwise treatments (such as medication, physical therapy, interventional injections, etc.); 5. No significant atrophy of lower limb muscles, and electromyography shows no evidence of lower motor neuron damage from L2 to S1.

Exclusion criteria

Exclusion criteria: 1. High risk of infection: skin infection at the surgical site, systemic infection, or spinal infection/tumor; 2. Coagulation disorders: platelets <50×10^9/L, or use of anticoagulants not discontinued; 3. Abnormal neural structures: space-occupying lesions in the spinal canal (such as tumors) or anatomical variations caused by previous surgery; 4. Severe systemic diseases: uncontrolled diabetes, cardiovascular or cerebrovascular diseases (history of cerebral infarction, refractory hypertension), liver or kidney failure, active gastrointestinal bleeding, etc.; 5. Neurological comorbidities: epilepsy, Parkinson's disease, severe traumatic brain injury, cognitive impairment (unable to understand SCS operation equipment or cooperate with neurological function examination, etc.); 6. Immune system dysfunction and deficiencies.

Design outcomes

Primary

MeasureTime frame
MMT unarmed muscle strength assessment;Modified Ashworth classification;Holden walking ability rating;Gait analysis;Electromyography data;

Countries

China

Contacts

Public ContactCao Xiaojian

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

xiaojiancao001@163.com+86 25 6830 6300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026